Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


MaxDiscovery™ Human IL-3 ELISA Test Kit

Product Description
The MaxDiscovery™ Human IL-3 ELISA Test Kit is designed for quantitative determination of the concentration of human IL-3 in serum, plasma, and cell culture supernatant. Human interleukin 3 (IL-3) is a glycoprotein of 133 amino acids after cleavage of a 19 amino acid signal sequence. It is a pleiotropic factor that can stimulate the proliferation, differentiation, and survival of pluripotent hematopoietic stem cells as well as various lineage-committed progenitors. IL-3 is produced by several cell types including activated human T cells, natural killer cells, mast cells, epithelial cells, stromal cells, keratinocytes, neuronsand astrocytes. At the amino acid level, there is only 29% homology between mouse and human IL-3. Consistent with this lack of homology, the proteins are species-specific in their actions. IL-3 exerts its biological activities through binding to heteromeric transmembrane receptors. It has been shown that IL-3 alone, or acting synergistically with other early acting hematopoietic growth factors including, IL-1, IL-6, stem cell factor, G-CSF, MGDF, and Flt-3 ligand, can support the proliferation of pluripotent hematopoietic stem cells and progenitor cells of various lineages. In addition to its effects on hematopoietic cells, IL-3 can stimulate human endothelial and smooth muscle cell proliferation and motility and can act as a neurotrophic factor with the ability to promote neuronal survival and enhance neurite outgrowth. IL-3-/- mice do appear to exhibit deficiencies in mast cell and basophil development in addition to compromised immunity to parasites and reductions in delayed hypersensitivity reactions.
Product MaxDiscovery™ Human IL-3 ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2117-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122
Email: info@biooscientific.com



Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!